To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

NCT02585947 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma, Burkitt's

Interventions

DRUG: Tenofovir

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]